Travere Therapeutics (NASDAQ:TVTX) Stock Price Expected to Rise, Citigroup Analyst Says
Travere Therapeutics (NASDAQ:TVTX – Get Free Report) had its price target upped by equities researchers at Citigroup from $31.00 to $35.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Citigroup’s price target suggests a potential upside of 69.49% from the stock’s current price. Other equities research […]
Travere Therapeutics (NASDAQ:TVTX – Get Free Report) had its price target upped by equities researchers at Citigroup from $31.00 to $35.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Citigroup’s price target suggests a potential upside of 69.49% from the stock’s current price. Other equities research […]
